# A Study to Assess Bioavailability & Food Effect of Different Liquid and Capsule Formulations of TMC435.

> **NCT01571570** · PHASE1 · COMPLETED · sponsor: **Janssen R&D Ireland** · enrollment: 72 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** TMC435 150 mg capsule
- **DRUG:** TMC435 150 mg oral suspension (20 mg/mL)
- **DRUG:** TMC435 150 mg oral solution (10 mg/mL)
- **DRUG:** TMC435 150 mg capsule concept K
- **DRUG:** TMC435 150 mg capsule concept L

## Key facts

- **NCT ID:** NCT01571570
- **Lead sponsor:** Janssen R&D Ireland
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2013-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01571570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01571570, "A Study to Assess Bioavailability & Food Effect of Different Liquid and Capsule Formulations of TMC435.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01571570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*